NSE - Delayed Quote INR

Archean Chemical Industries Limited (ACI.NS)

553.95
-26.40
(-4.55%)
At close: 3:30:03 PM GMT+5:30
Loading Chart for ACI.NS
  • Previous Close 580.35
  • Open 561.00
  • Bid --
  • Ask --
  • Day's Range 544.30 - 577.95
  • 52 Week Range 408.35 - 832.00
  • Volume 915,107
  • Avg. Volume 715,719
  • Market Cap (intraday) 68.667B
  • Beta (5Y Monthly) 0.45
  • PE Ratio (TTM) 42.22
  • EPS (TTM) 13.12
  • Earnings Date Jul 31, 2025 - Aug 4, 2025
  • Forward Dividend & Yield 3.00 (0.52%)
  • Ex-Dividend Date May 26, 2025
  • 1y Target Est 689.86

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.

www.archeanchemicals.com

--

Full Time Employees

March 31

Fiscal Year Ends

Chemicals

Industry

Recent News: ACI.NS

View More

Performance Overview: ACI.NS

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ACI.NS
17.27%
S&P BSE SENSEX (^BSESN)
1.68%

1-Year Return

ACI.NS
10.51%
S&P BSE SENSEX (^BSESN)
9.74%

3-Year Return

ACI.NS
23.10%
S&P BSE SENSEX (^BSESN)
45.87%

5-Year Return

ACI.NS
23.10%
S&P BSE SENSEX (^BSESN)
151.10%

Compare To: ACI.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACI.NS

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    71.94B

  • Enterprise Value

    71.53B

  • Trailing P/E

    44.23

  • Forward P/E

    19.68

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.89

  • Price/Book (mrq)

    3.84

  • Enterprise Value/Revenue

    6.87

  • Enterprise Value/EBITDA

    22.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.58%

  • Return on Assets (ttm)

    6.60%

  • Return on Equity (ttm)

    9.10%

  • Revenue (ttm)

    10.41B

  • Net Income Avi to Common (ttm)

    1.62B

  • Diluted EPS (ttm)

    13.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.55B

  • Total Debt/Equity (mrq)

    12.58%

  • Levered Free Cash Flow (ttm)

    -1.18B

Research Analysis: ACI.NS

View More

Company Insights: ACI.NS

Research Reports: ACI.NS

View More

People Also Watch